Arcturus Therapeutics Holdings (ARCT) Gains from Equity Investments (2019 - 2020)
Arcturus Therapeutics Holdings (ARCT) reported Gains from Equity Investments of $100000.0 for Q2 2020, down 38.65% quarter-over-quarter from $163000.0 in Q1 2020.
Arcturus Therapeutics Holdings (ARCT) Gains from Equity Investments (2019 - 2020) Analysis & Trends
Arcturus Therapeutics Holdings has reported Gains from Equity Investments for 2 years, with the latest figure at $100000.0 in Q2 2020.
- For the quarter ending Q2 2020, Gains from Equity Investments changed N/A year-over-year to $100000.0; the trailing twelve-month figure through Jun 2020 stood at $551000.0 (changed N/A YoY), and the FY2020 full-year result was $263000.0, up 952.0% from the prior year.
- Gains from Equity Investments for Q2 2020 stood at $100000.0, down from $163000.0 in the prior quarter.
- The five-year high for Gains from Equity Investments was $288000.0 in Q1 2019, with the low at $100000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arcturus Therapeutics Holdings | 217.14 Mn | 5.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 100,000.00 |
| Jun 30, 2020 | 100,000.00 |
| Mar 31, 2020 | 163,000.00 |
| Mar 31, 2020 | 163,000.00 |
| Mar 31, 2019 | 288,000.00 |
| Mar 31, 2019 | 288,000.00 |